Companies/JP/4543

TERUMO CORPORATION · テルモ株式会社

Income flow

Annual
4543 ANNUAL Income StatementPeriod 2026-03-31Source ANNUAL
Cardiac And Vascular CompanyJPY 676BBlood And Cell Technologies CompanyJPY 231BMedical Care Solutions CompanyJPY 216BTerumo Organ TechnologiesJPY 8BRevenueJPY 1132B+9% Y/YGross profitJPY 595B+6% Y/YCost of revenueJPY 537BOperating profitJPY 176B+12% Y/YOperating expensesJPY 418BNet profitJPY 136B+16% Y/YTaxJPY 42BOperating expensesJPY 418B

As-filed revenue segments and annual P&L (gross, opex, tax, net). Layout inspired by SankeyArt finance diagrams.

Revenue mix

2026-03-31 · ANNUAL · JPY
By activity
By activityJPY 1131.6B
  • Cardiac And Vascular CompanyJPY 676.4B59.8%
  • Blood And Cell Technologies CompanyJPY 231.0B20.4%
  • Medical Care Solutions CompanyJPY 216.1B19.1%
  • Terumo Organ TechnologiesJPY 8.0B0.7%

Capital & dividends

YieldTrailing twelve-month dividends as a percent of the current share price (income yield).1.56%5y avgAverage dividend yield over the past five years — a smoother view than the latest print.0.92%Trailing DPSCash dividends paid per share over the last twelve months (dividend per share, trailing).30PayoutShare of earnings paid out as dividends. Higher means more income returned; lower leaves more for reinvestment.26.9%Shares outTotal shares currently outstanding (issued and not retired).1.48BFloatShares available to trade — outstanding minus closely held (insiders, strategic holders).1.45B
Upcoming dividend
Next ex-div
2027-03-30 · declared
Last cash
18 · 2027-03-30
Stock splits
  1. 2:12024-03-28
  2. 2:12019-03-27